Thursday, March 3, 2011

International Stem Cell Corporation's Senior VP Jeffrey Janus Comments on "ACT Awarded Patent for Stem Cell Generation Technique"


"The granting of this patent is an excellent step forward in the search for new techniques to derive stem cells and treat diseases with stem cell therapy. As a licensee of this technology for several of our target stem cell applications, we at International Stem Cell Corporation are delighted that our scientists have yet another tool with which to work."

Jeffrey Janus, Senior VP, International Stem Cell

No comments:

Post a Comment